Last Chance to Register: Don’t Miss the Next Total Pharmacy Solutions Summit
Drug Topics
MARCH 31, 2023
The theme of the upcoming Summit is the Expansion of Services Within Independent Pharmacy.
Drug Topics
MARCH 31, 2023
The theme of the upcoming Summit is the Expansion of Services Within Independent Pharmacy.
Fierce Healthcare
MARCH 31, 2023
CMS to raise Medicare Advantage pay rates by 3.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 31, 2023
In the world of medication, packaging can make all the difference. Sead Ferhatovic from Jones Healthcare Group joins Drug Topics to talk about blister packs, automation in prescription packaging, and more.
PharmaVoice
MARCH 31, 2023
The major challenges pharma leaders would solve with a quick flick of an imaginary wand.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 31, 2023
Your weekly roundup of the latest news from Drug Topics®.
Fierce Healthcare
MARCH 31, 2023
DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care hlandi Fri, 03/31/2023 - 14:32
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 31, 2023
Clinicians know the odds tend to be stacked against Black breast cancer patients. They get more dangerous and aggressive subtypes of breast cancer more frequently than white patients. Within breast cancer subtypes, Black patients tend to have worse outcomes compared to white negative patients, too. But what biological factors contribute to these disparities – and how much – is an open question.
European Pharmaceutical Review
MARCH 31, 2023
The Medicines Patent Pool (MPP) has signed sublicence agreements with three generics manufacturers to produce generic versions of cabotegravir long-acting (LA) injectable for human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). First sublicence agreement signed by MPP for a long-acting medicine Through the sublicences, the selected generic manufacturers will be able to develop, manufacture, and supply generic versions of cabotegravir LA for PrEP, in 90 countries, subject to requir
STAT
MARCH 31, 2023
Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019. Yet many sponsored research collaborations that hope to tap into academia fail. Academic-industry partnerships present a unique set of challenges that require thoughtful setup and dedicated execution from both the company and academic institution.
Fierce Healthcare
MARCH 31, 2023
Despite court ruling, insurers say they will continue to offer ACA-mandated free preventive services fdiamond Fri, 03/31/2023 - 13:33
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 31, 2023
Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed to follow numerous procedures to ensure its products did not become contaminated, according to a Food and Drug Administration inspection report obtained by STAT. During a recent visit to the facility in Tamil Nadu, India, agency inspectors found the company failed to take basic steps during sterilization, relied on deficient manufacturing processes and methods to ensure and verify sterility, and did
The Checkup by Singlecare
MARCH 31, 2023
This week the U.S. Food and Drug Administration (FDA) approved a non-prescription version of Narcan (naloxone), a nasal spray used to rapidly reverse the effects of an opioid overdose. This marks the first time an over-the-counter version of this life-saving medication will be available. “Naloxone is a critical tool in addressing opioid overdoses, and today’s approval underscores the extensive efforts the agency has undertaken to combat the overdose crisis,” said Patrizia Cavazzoni, MD, directo
STAT
MARCH 31, 2023
Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drug makers increased their wholesale prices by 5% in the fourth quarter last year, up from 4.3% a year earlier and 4.9% in the previous quarter. But when accounting for inflation, wholesale prices fell by 3%, although further changes this year are likely to more closely mirror inflation.
Drug Store News
MARCH 31, 2023
Kellogg’s Little Debbie Swiss Rolls cereal contains crispy and chocolatey swirls with a chocolatey crème flavored coating, the companies said.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MARCH 31, 2023
WASHINGTON — The Biden administration backed off some of its plans to rein in billions of dollars from wasteful spending in Medicare Advantage next year, after intense lobbying from health insurance companies. The administration will now phase in its changes to Medicare Advantage’s so-called risk adjustment program over three years, rather than all at once, softening the immediate blow to the companies’ payments and stretching out the timeline for reining in the spending.
European Pharmaceutical Review
MARCH 31, 2023
“The access to increased capital… could allow for the potential for biopharmaceutical companies to improve investment in the development of therapies.” Following the collapse of Silicon Valley Bank (SVB), HSBC’s acquisition of Silicon Valley Bank (SVP) UK may offer new opportunities for biopharmaceutical companies, according to data and analytics firm, GlobalData.
Drug Store News
MARCH 31, 2023
Customers with FIS and Soda Health-integrated benefit cards will now be able to make purchases on eligible food and health items at Albertsons’ banner stores including Safeway, Albertsons, Jewel-Osco, Vons, Shaw’s, Tom Thumb and ACME.
European Pharmaceutical Review
MARCH 31, 2023
An innovative liquid chromatography (LC)—high resolution mass spectrometry method could quickly and correctly identify all Candida auris isolates with 99.6 percent confidence, a study has shown. Mass spectrometry (MALDI-TOF) has entered many clinical microbiology laboratories during the past decade. It has gradually replaced biochemical methods as the preferred tool for pathogen identification, the researchers noted.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
MARCH 31, 2023
Flavors the retailer will carry include strawberry milkshake, watermelon mint and the Target-exclusive fruity cereal.
STAT
MARCH 31, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Drug Store News
MARCH 31, 2023
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines.
Fierce Healthcare
MARCH 31, 2023
CVS expects to close Oak Street Health deal by July as acquisition clears regulatory obstacle hlandi Fri, 03/31/2023 - 12:05
Drug Store News
MARCH 31, 2023
The session will focus on streamlining the fixture reset process by employing processes to facilitate reuse of componentry to decrease waste, reduce labor hours and increase profitability.
PharmExec
MARCH 31, 2023
Rohit Gupta, vice president of analytics strategy and transformation at Beghou Consulting, addresses the controversial middlemen of the drug pricing world, the pharmacy benefit managers (PBMs). Can increased competition and other innovative solutions loosen their grip and prevent further consolidation?
Drug Store News
MARCH 31, 2023
Michael Abrams, M.A., managing partner at Numerof & Associates, spoke to DSN about improving health care delivery.
Fierce Healthcare
MARCH 31, 2023
Trustees predict Medicare hospital fund to run out in 2031, three years later than 2022 report rking Fri, 03/31/2023 - 13:22
Drug Store News
MARCH 31, 2023
The award was established in 2022 to recognize individuals who have created a long-lasting impact supporting public health via self-care for at least 20 years.
Fierce Pharma
MARCH 31, 2023
Biogen comes out ahead in investor lawsuit over Aduhelm disclosures zbecker Fri, 03/31/2023 - 11:06
Drug Store News
MARCH 31, 2023
The brand's new Air Dry Styling Lotion and Air Dry Styler Gel are formulated to reduce drying time while maintaining moisture and shine.
Fierce Healthcare
MARCH 31, 2023
HHS appeals judge's ruling on ACA preventive care pminemyer Fri, 03/31/2023 - 17:53
Fierce Pharma
MARCH 31, 2023
After Amarin's clash with Sarissa, CEO Mikhail hits the exit esagonowsky Fri, 03/31/2023 - 10:52
Pharmafile
MARCH 31, 2023
Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation or stenosis. The device is the newest in Abbott’s Epic surgical valve platform which the company has been developing for decades with positive results. Aortic regurgitation refers to when the aortic valve cannot close properly, while aortic stenosis refers to when it fails to open fully, both meaning the heart cannot pump blood effectively and blood flow to the body is red
Fierce Pharma
MARCH 31, 2023
Seeking full approval in Alzheimer's, Eisai dives into prominent Leqembi side effect fkansteiner Fri, 03/31/2023 - 11:30
Let's personalize your content